HOXB1 and central nervous system cancer: Univariate Cox regression models showed that only HOXB1 expression (hazards ratio [HR] 0.055, P = 0.004, 95% confidence interval [95% CI] 0.008–0.394) was associated with worse survival in this prospective cohort of glioma patients (Table 1).